Whittier Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20
Closed 1524
2020
Q3
$0 Hold
20
﹤0.01% 1554
2020
Q2
$0 Hold
20
﹤0.01% 1575
2020
Q1
$0 Hold
20
﹤0.01% 1663
2019
Q4
$0 Sell
20
-1,260
-98% -$3.66K ﹤0.01% 1671
2019
Q3
$3K Buy
1,280
+1,260
+6,300% +$3.37K ﹤0.01% 1352
2019
Q2
$0 Hold
20
﹤0.01% 1509
2019
Q1
$0 Hold
20
﹤0.01% 1553
2018
Q4
$0 Hold
20
﹤0.01% 1417
2018
Q3
$0 Hold
20
﹤0.01% 1315
2018
Q2
$0 Hold
20
﹤0.01% 1376
2018
Q1
$0 Hold
20
﹤0.01% 1384
2017
Q4
$0 Hold
20
﹤0.01% 1400
2017
Q3
$0 Hold
20
﹤0.01% 1383
2017
Q2
$0 Hold
20
﹤0.01% 1392
2017
Q1
$0 Hold
20
﹤0.01% 1422
2016
Q4
$0 Hold
20
﹤0.01% 1260
2016
Q3
$0 Hold
20
﹤0.01% 1245
2016
Q2
$0 Hold
20
﹤0.01% 1254
2016
Q1
$0 Hold
20
﹤0.01% 1270
2015
Q4
$0 Hold
20
﹤0.01% 1295
2015
Q3
$0 Hold
20
﹤0.01% 1283
2015
Q2
$0 Hold
20
﹤0.01% 1344
2015
Q1
$0 Hold
20
﹤0.01% 1279
2014
Q4
$0 Hold
20
﹤0.01% 1128
2014
Q3
$0 Hold
20
﹤0.01% 1086
2014
Q2
$0 Hold
20
﹤0.01% 1102
2014
Q1
$0 Hold
20
﹤0.01% 1119
2013
Q4
$0 Hold
20
﹤0.01% 1138
2013
Q3
$0 Hold
20
﹤0.01% 1105
2013
Q2
$0 Buy
+20
New +$156 ﹤0.01% 1091

Other funds holding PDLI

Whittier Trust's PDLI Position: Q4 2020 in Review

Whittier Trust sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 20 shares.

Whittier Trust first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $3K in Q3 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Whittier Trust reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Whittier Trust sold 20 PDL BioPharma, Inc. shares in Q4 2020.
  • Whittier Trust first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Whittier Trust's PDL BioPharma, Inc. position peaked at $3K in Q3 2019.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Whittier Trust's 13F filing for Q4 2020, filed 29 Jan 2021.